AKEBIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.14 USD | -3.39% |
|
-18.57% | -8.06% |
| 09/05 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 09/05 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Bio Therapeutic Drugs | -3.39% | -18.57% | -8.06% | +4.59% | -80.31% | 247M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AKBA Stock
- Charts Akebia Therapeutics, Inc.
- Comparison Chart
